COO Tom Mitro Discusses Aerie’s Preparation for Rhopressa Launch, Updates OIS@ASCRS on Pipeline - a podcast by OIS Podcast
from 2017-05-31T00:00
::
::
In this interview, Tom Mitro, COO of Aerie Pharmaceuticals, says new hires brought on to prepare for likely commercial sale of Rhopressa bring new life and energy into a company hitting its stride. He also provides to OIS@ASCRS an update on the firm’s glaucoma pipeline.
Further episodes of OIS Podcast | Ophthalmology
Further podcasts by OIS Podcast
Website of OIS Podcast